Devyser Diagnostics AB (publ) (DVYSR.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -2.39%; 2025 (actual)
ROA: -1.78%; 2025 (actual)
Gross Margin: 80.6%; 2025 (actual)
Net Margin: -3.35%; 2025 (actual)
Total Assets: SEK 469,700.00K; 2025 (actual)
Net Income: -SEK 8,400.00K; 2025 (actual)
Valuation: SEK 1,928,815.85K; 2025 (actual)
Stock Price: SEK 114.20; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-2.39%	-0.56%	-0.21%	-0.56%	-0.59%	-0.61%
ROA	-1.78%	-0.42%	-0.15%	-0.4%	-0.41%	-0.42%
Gross Margin	80.6%	80.6%	80.6%	80.6%	80.6%	80.6%
Sector average	16.85%	17.71%	17.71%	17.71%	17.71%	17.71%
Net Margin

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Devyser Diagnostics AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	SEK 469,700.00K	SEK 474,925.19K	SEK 481,890.40K	SEK 491,510.61K	SEK 500,243.27K	SEK 504,806.54K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K

Net Income	-SEK 8,400.00K	-SEK 1,964.42K	-SEK 739.82K	-SEK 1,965.79K	-SEK 2,055.32K	-SEK 2,120.03K
Sector average	-SEK 2,851.32K	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K

Valuation	SEK 1,928,815.85K	SEK 964,407.93K	SEK 482,203.96K	SEK 964,407.93K	SEK 1,008,329.37K	SEK 1,040,073.94K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 114.20	SEK 57.10	SEK 28.55	SEK 57.10	SEK 59.70	SEK 61.58
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41